Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML.

Mohamed AM, Balsat M, Koering C, Maucort-Boulch D, Boissel N, Payen-Gay L, Cheok M, Mortada H, Auboeuf D, Pinatel C, El-Hamri M, Tigaud I, Hayette S, Dumontet C, Cros E, Flandrin-Gresta P, Nibourel O, Preudhomme C, Thomas X, Nicolini FE, Solly F, Guyotat D, Campos L, Michallet M, Ceraulo A, Mortreux F, Wattel E.

Leuk Res. 2017 May;56:21-28. doi: 10.1016/j.leukres.2017.01.012. Epub 2017 Jan 16.

PMID:
28167452
2.

An miRNA-DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia.

Solly F, Koering C, Mohamed AM, Maucort-Boulch D, Robert G, Auberger P, Flandrin-Gresta P, Adès L, Fenaux P, Kosmider O, Tavernier-Tardy E, Cornillon J, Guyotat D, Campos L, Mortreux F, Wattel E.

Clin Cancer Res. 2017 Jun 15;23(12):3025-3034. doi: 10.1158/1078-0432.CCR-16-2304. Epub 2016 Nov 23.

3.

HBx triggers either cellular senescence or cell proliferation depending on cellular phenotype.

Idrissi ME, Hachem H, Koering C, Merle P, Thénoz M, Mortreux F, Wattel E.

J Viral Hepat. 2016 Feb;23(2):130-8. doi: 10.1111/jvh.12450. Epub 2015 Aug 28.

PMID:
26316075
4.

Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML).

Mohamed AM, Balsat M, Thenoz M, Koering C, Payen-Gay L, Cheok M, Mortada H, Auboeuf D, Pinatel C, El-Hamri M, Dumontet C, Cros E, Flandrin-Gresta P, Nibourel O, Preudhomme C, Michallet M, Thomas X, Nicolini F, Solly F, Guyotat D, Campos L, Wattel E, Mortreux F.

Oncotarget. 2016 Jan 19;7(3):2889-909. doi: 10.18632/oncotarget.3898.

5.

TRF2 inhibition triggers apoptosis and reduces tumourigenicity of human melanoma cells.

Biroccio A, Rizzo A, Elli R, Koering CE, Belleville A, Benassi B, Leonetti C, Stevens MF, D'Incalci M, Zupi G, Gilson E.

Eur J Cancer. 2006 Aug;42(12):1881-8. Epub 2006 Jun 5.

PMID:
16750909
6.

TRF2 inhibition promotes anchorage-independent growth of telomerase-positive human fibroblasts.

Brunori M, Mathieu N, Ricoul M, Bauwens S, Koering CE, Roborel de Climens A, Belleville A, Wang Q, Puisieux I, Décimo D, Puisieux A, Sabatier L, Gilson E.

Oncogene. 2006 Feb 16;25(7):990-7.

PMID:
16205637
7.

Functional interaction between poly(ADP-Ribose) polymerase 2 (PARP-2) and TRF2: PARP activity negatively regulates TRF2.

Dantzer F, Giraud-Panis MJ, Jaco I, Amé JC, Schultz I, Blasco M, Koering CE, Gilson E, Ménissier-de Murcia J, de Murcia G, Schreiber V.

Mol Cell Biol. 2004 Feb;24(4):1595-607.

8.

Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.

Nakanishi K, Kawai T, Kumaki F, Hiroi S, Mukai M, Ikeda E, Koering CE, Gilson E.

Clin Cancer Res. 2003 Mar;9(3):1105-11.

9.

Human telomeric position effect is determined by chromosomal context and telomeric chromatin integrity.

Koering CE, Pollice A, Zibella MP, Bauwens S, Puisieux A, Brunori M, Brun C, Martins L, Sabatier L, Pulitzer JF, Gilson E.

EMBO Rep. 2002 Nov;3(11):1055-61. Epub 2002 Oct 22.

10.

Targeting assay to study the cis functions of human telomeric proteins: evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2.

Ancelin K, Brunori M, Bauwens S, Koering CE, Brun C, Ricoul M, Pommier JP, Sabatier L, Gilson E.

Mol Cell Biol. 2002 May;22(10):3474-87.

11.

Identification of high affinity Tbf1p-binding sites within the budding yeast genome.

Koering CE, Fourel G, Binet-Brasselet E, Laroche T, Klein F, Gilson E.

Nucleic Acids Res. 2000 Jul 1;28(13):2519-26. doi: 10.1093/nar/28.13.2519.

12.

Cohabitation of insulators and silencing elements in yeast subtelomeric regions.

Fourel G, Revardel E, Koering CE, Gilson E.

EMBO J. 1999 May 4;18(9):2522-37.

13.

Telomeric localization of TRF2, a novel human telobox protein.

Bilaud T, Brun C, Ancelin K, Koering CE, Laroche T, Gilson E.

Nat Genet. 1997 Oct;17(2):236-9.

PMID:
9326951
14.

Sensitivity to the parvovirus minute virus of mice as a probe for azatyrosine-mediated phenotypic reversion of spontaneously transformed cells.

Koering CE, Vennin-Fikry M, Dupressoir T, Schlehofer JR, Rommelaere J, Stehelin D.

J Gen Virol. 1996 May;77 ( Pt 5):913-7.

PMID:
8609487
15.

The telobox, a Myb-related telomeric DNA binding motif found in proteins from yeast, plants and human.

Bilaud T, Koering CE, Binet-Brasselet E, Ancelin K, Pollice A, Gasser SM, Gilson E.

Nucleic Acids Res. 1996 Apr 1;24(7):1294-303.

16.

Continuous production of minute virus of mice by an untransformed variant of Fisher rat fibroblast (FR3T3).

Koering CE, Geuskens M, Rommelaere J.

J Gen Virol. 1996 Mar;77 ( Pt 3):447-52.

PMID:
8601780
17.

Induced expression of the conditionally cytotoxic herpes simplex virus thymidine kinase gene by means of a parvoviral regulatory circuit.

Koering CE, Dupressoir T, Plaza S, Stehelin D, Rommelaere J.

Hum Gene Ther. 1994 Apr;5(4):457-63.

PMID:
8049302

Supplemental Content

Loading ...
Support Center